Healthcare Services

Cell viability assays market insights highlighting opportunities

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Cell Viability Assays Market During The Forecast Period?

The cell viability assays market size has experienced swift expansion recently. It is forecast to rise from $1.73 billion in 2025 to $1.91 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.5%. The historical increase in this market can be attributed to factors such as the expansion of in vitro research activities, increasing pharmaceutical R&D spending, growth in toxicology testing, the rising use of cell culture models, and the availability of standardized assay kits.

The cell viability assays market is projected to experience substantial expansion over the coming years. This market is anticipated to reach $2.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.3%. Several factors will drive this growth during the forecast period, including the surging demand for high-throughput drug discovery, the increasing adoption of automated assay platforms, the broadening scope of personalized medicine research, an intensifying focus on assay miniaturization, and the rising integration of imaging-based viability analysis. Key trends emerging within the forecast period encompass the greater uptake of high-sensitivity viability assays, the expanding utilization of microplate-based detection systems, an escalating need for multiparametric cell health analysis, the enlargement of drug screening applications, and a heightened emphasis on reproducible assay protocols.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

What Leading Drivers Are Supporting The Cell Viability Assays Market Expansion?

The growing number of cell-based therapeutics is anticipated to fuel the expansion of the cell viability assay market moving forward. Cell-based therapeutics encompass treatments that employ living cells to repair or replace damaged tissue, address illnesses, or restore normal functioning. The advancement in cell-based therapeutics is driven by innovations in biotechnology, increased investments in regenerative medicine, a broader embrace and utilization of cell therapies, and improvements in cell engineering and production technologies. Cell viability assays aid cell-based therapeutics by confirming the health, performance, and safety of therapeutic cells, thereby enhancing treatment effectiveness and quality assurance. For instance, in 2023, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the quantity of gene therapies in Phase III clinical trials rose by 10% in Q3 2023, marking the initial quarterly increase recorded since Q3 2022. Consequently, the increasing cell-based therapeutics is propelling the growth of the cell viability assay market.

How Is The Cell Viability Assays Market Segmented Across Different Segment Categories?

The cell viability assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Consumables: Reagents, Kits, Assay Plates (96-Well plates), Microplates

2) By Instruments: Spectrophotometers, Fluorometers, Microplate Readers, Flow Cytometers, Imaging Systems

What Emerging Trends Are Seen In The Cell Viability Assays Market?

Leading companies active in the cell viability assays market are innovating cell screening technologies to boost accuracy and accelerate drug discovery. These cell screening innovations enhance cell viability assays by enabling high-throughput, accurate, and swift examination of cellular well-being and responses, thereby optimizing experimental environments and refining therapeutic strategy development. As an illustration, in May 2024, Arralyze, a technology company headquartered in Germany, unveiled CellShepherd, an advanced platform designed for single-cell analysis. This platform employs exclusive nanowell glass arrays to miniaturize assays based on cells, allowing for real-time observation. The self-contained system provides accurate cell dispensing, co-cultivation in sterile settings, and imaging using both brightfield and fluorescent channels. Its AI-powered analysis ensures precise cell enumeration and monitoring. This easy-to-use platform meets the growing demand for accurate single-cell investigations across biomedical and life science fields.

Which Organizations Play A Role In The Cell Viability Assays Market Landscape?

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Get The Full Cell Viability Assays Market Report:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Where Is The Cell Viability Assays Market Primarily Concentrated By Region?

North America was the largest region in the cell viability assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cell Viability Assays Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

Browse Through More Reports Similar to the Global Cell Viability Assays Market 2026, By The Business Research Company

In Vitro Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Cell Based Assays Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Stem Cell Assay Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795